Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course

Abstract

Background. Although current guidelines advocate early integration of palliative care, symptom burden and palliative care needs of patients at diagnosis of incurable cancer and along the disease trajectory are understudied. Material and Methods. We assessed distress, symptom burden, quality of life, and supportive care needs in patients with newly diagnosed incurable cancer in a prospective longitudinal observational multicentre study. Patients were evaluated using validated self-report measures (NCCN Distress Thermometer (DT), FACT, SEIQoL-Q, PHQ-4, modified SCNS-SF-34) at baseline (T0), at three (T1), six (T2), and twelve months (T3) follow-up. Results. From 10/2014 to 10/2016, 500 patients (219 women, 281 men; mean age 64.2 years) were recruited at 20 study sites in Germany following diagnosis of incurable metastatic , locally advanced, or recurrent lung (217), gastrointestinal (156), head and neck (55), gynecological (57) and skin (15) cancer. Patients reported significant distress (DT score ≥5) after diagnosis, which significantly decreased over time (T0: 67.2%, T1: 51.7%, T2: 47.9%, T3: 48.7%). The spectrum of reported symptoms was broad with considerable variety between and within the cancer groups. Anxiety and depressiveness were most prevalent early in the disease course (T0: 30.8%, T1: 20.1%, T2: 14.7%, T3: 16.9%). The number of patients reporting unmet supportive care needs decreased over time (T0: 71.8 %, T1: 61.6%, T2: 58.1%, T3: 55.3%). Conclusion. Our study confirms a variable and mostly high symptom burden at the time of diagnosis of incurable cancer, suggesting early screening by using standardized tools, and underlining the usefulness of early palliative care. Implication for practice. A better understanding of symptom burden and palliative care needs of patients with newly diagnosed incurable cancer may guide clinical practice and help to improve the quality of palliative care services. Our study results provide important information for establishing palliative care programs and related guidelines. Distress, symptom burden and the need for support vary, and are often high at the time of diagnosis. These findings underscore the need for implementation of symptom screening

Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs: A randomized controlled trial

“…Incurable cancer challenges patients to deal with physical, psychological and social symptoms, and existential concerns, affecting aspects of their health-related quality of life (HRQOL). 1 , 2 Maintaining optimal HRQOL by early identification of symptoms and providing access to palliative care services if needed, is an important aspect of palliative care.…”

Containing Cancer with Personalized Minimum Effective Dose

“…The definition of tolerable tumor volume that is related to the quality of life is obscure 57 , as it is associated with multidimensional factors, such as symptom burden, age, cancer type, and patient expectations. For instance, in a longitudinal study of approximately 500 patients with different types of cancer, patients with stomach, esophageal, hepatobiliary, or head and neck cancer had higher distress levels than other patients 58 . In addition, in phase III trials of prostate cancer, it has been reported that stabilizing the symptom burden is not correlated with the survival rate 59 .…”

Longitudinal symptoms and temporal trends in palliative care, palliative radiotherapy, and anti-cancer treatment near end of life among patients with metastatic cancer

“…At the time of diagnosis of incurable cancer, many patients experience a high symptom burden including pain and fatigue (17)(18)(19). Nearly 80% of patients with metastatic cancer also present with symptomatic disease at the time of palliative RT consultation (20).…”